Results 121 to 130 of about 676 (154)
Some of the next articles are maybe not open access.

Impact of elosulfase alfa on pain in patients with Morquio syndrome type A

Molecular Genetics and Metabolism, 2015
Paul Harmatz   +12 more
openaire   +1 more source

Elosulfase alfa

Reactions Weekly, 2016
openaire   +1 more source

NICE recommends elosulfase alfa

The Pharmaceutical Journal, 2016
openaire   +1 more source

Elosulfase alfa treatment and changes in physical functioning and disability in Morquio syndrome type A

Molecular Genetics and Metabolism, 2017
Christian J. Hendriksz   +13 more
openaire   +1 more source

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Lancet, The, 2007
Alain Ravaud   +2 more
exaly  

Australian Government to fund elosulfase alfa

PharmacoEconomics & Outcomes News, 2017
openaire   +1 more source

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Lancet, The, 2005
Harry La Janssen   +2 more
exaly  

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

Journal of Clinical Oncology, 2008
Brian I Rini, Susan Halabi
exaly  

Sub-analysis of long-term elosulfase alfa treatment outcomes in adults with Morquio syndrome type A

Molecular Genetics and Metabolism, 2017
Derralynn Hughes   +8 more
openaire   +1 more source

The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications

Nature Communications, 2019
Hansjörg Götzke   +2 more
exaly  
enzyme replacement therapy
mucopolysaccharidosis iva
morquio a syndrome
mucopolysaccharidosis
mps iva
medicine general
morquio a
morquio syndrome
mucopolysaccharidosis type iva
previous   11  12  13  14  15  16  

Home - About - Disclaimer - Privacy